Global Digital Companion Diagnostics Market Research Report 2023

Digital Companion Diagnostics Market

A companion diagnostic is a medical device, often an in vitro device, which provides information that is essential for the safe and effective use of a corresponding drug or biological product. The test helps a health care professional determine whether a particular therapeutic product’s benefits to patients will outweigh any potential serious side effects or risks.Digital Companion Diagnostics (CD) refer to a type of in vitro diagnostic tests or assays that are intended to help physicians in making effective treatment decisions based on the patient’s response to a specific drug targeted toward a specific biomarker, expressed in a particular disease or indication. The patient’s response to an ongoing therapy is mapped with the help of companion diagnostics in terms of changes in gene amplification, nullifying the effect of mutations, changes in protein overexpression and receptor-substrate interaction, and so on.

According to new survey, global Digital Companion Diagnostics market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Digital Companion Diagnostics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of Digital Companion Diagnostics Market Report

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Digital Companion Diagnostics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Polymerase Chain Reaction (PCR)

1.2.3 Immunohistochemistry (IHC)

1.2.4 In Situ Hybridization (ISH)

1.2.5 Next Generation Sequencing (NGS)

1.3 Market by Application

1.3.1 Global Digital Companion Diagnostics Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Breast Cancer

1.3.3 Melanoma

1.3.4 Lung Cancer

1.3.5 Colorectal Cancer

1.3.6 Infectious Disease

1.3.7 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Digital Companion Diagnostics Market Perspective (2018-2029)

2.2 Digital Companion Diagnostics Growth Trends by Region

2.2.1 Global Digital Companion Diagnostics Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Digital Companion Diagnostics Historic Market Size by Region (2018-2023)

2.2.3 Digital Companion Diagnostics Forecasted Market Size by Region (2024-2029)

2.3 Digital Companion Diagnostics Market Dynamics

2.3.1 Digital Companion Diagnostics Industry Trends

2.3.2 Digital Companion Diagnostics Market Drivers

2.3.3 Digital Companion Diagnostics Market Challenges

2.3.4 Digital Companion Diagnostics Market Restraints

3.1 Global Top Digital Companion Diagnostics Players by Revenue

3.1.1 Global Top Digital Companion Diagnostics Players by Revenue (2018-2023)

3.1.2 Global Digital Companion Diagnostics Revenue Market Share by Players (2018-2023)

3.2 Global Digital Companion Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Digital Companion Diagnostics Revenue

3.4 Global Digital Companion Diagnostics Market Concentration Ratio

3.4.1 Global Digital Companion Diagnostics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Digital Companion Diagnostics Revenue in 2022

3.5 Digital Companion Diagnostics Key Players Head office and Area Served

3.6 Key Players Digital Companion Diagnostics Product Solution and Service

3.7 Date of Enter into Digital Companion Diagnostics Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Digital Companion Diagnostics Historic Market Size by Type (2018-2023)

4.2 Global Digital Companion Diagnostics Forecasted Market Size by Type (2024-2029)

5.1 Global Digital Companion Diagnostics Historic Market Size by Application (2018-2023)

5.2 Global Digital Companion Diagnostics Forecasted Market Size by Application (2024-2029)

6.1 North America Digital Companion Diagnostics Market Size (2018-2029)

6.2 North America Digital Companion Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Digital Companion Diagnostics Market Size by Country (2018-2023)

6.4 North America Digital Companion Diagnostics Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Digital Companion Diagnostics Market Size (2018-2029)

7.2 Europe Digital Companion Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Digital Companion Diagnostics Market Size by Country (2018-2023)

7.4 Europe Digital Companion Diagnostics Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Digital Companion Diagnostics Market Size (2018-2029)

8.2 Asia-Pacific Digital Companion Diagnostics Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Digital Companion Diagnostics Market Size by Region (2018-2023)

8.4 Asia-Pacific Digital Companion Diagnostics Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Digital Companion Diagnostics Market Size (2018-2029)

9.2 Latin America Digital Companion Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Digital Companion Diagnostics Market Size by Country (2018-2023)

9.4 Latin America Digital Companion Diagnostics Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Digital Companion Diagnostics Market Size (2018-2029)

10.2 Middle East & Africa Digital Companion Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Digital Companion Diagnostics Market Size by Country (2018-2023)

10.4 Middle East & Africa Digital Companion Diagnostics Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Myriad Genetic Laboratories, Inc.

11.1.1 Myriad Genetic Laboratories, Inc. Company Detail

11.1.2 Myriad Genetic Laboratories, Inc. Business Overview

11.1.3 Myriad Genetic Laboratories, Inc. Digital Companion Diagnostics Introduction

11.1.4 Myriad Genetic Laboratories, Inc. Revenue in Digital Companion Diagnostics Business (2018-2023)

11.1.5 Myriad Genetic Laboratories, Inc. Recent Development

11.2 Qiagen Manchester, Ltd.

11.2.1 Qiagen Manchester, Ltd. Company Detail

11.2.2 Qiagen Manchester, Ltd. Business Overview

11.2.3 Qiagen Manchester, Ltd. Digital Companion Diagnostics Introduction

11.2.4 Qiagen Manchester, Ltd. Revenue in Digital Companion Diagnostics Business (2018-2023)

11.2.5 Qiagen Manchester, Ltd. Recent Development

11.3 Roche

11.3.1 Roche Company Detail

11.3.2 Roche Business Overview

11.3.3 Roche Digital Companion Diagnostics Introduction

11.3.4 Roche Revenue in Digital Companion Diagnostics Business (2018-2023)

11.3.5 Roche Recent Development

11.4 Dako North America

11.4.1 Dako North America Company Detail

11.4.2 Dako North America Business Overview

11.4.3 Dako North America Digital Companion Diagnostics Introduction

11.4.4 Dako North America Revenue in Digital Companion Diagnostics Business (2018-2023)

11.4.5 Dako North America Recent Development

11.5 Abbott

11.5.1 Abbott Company Detail

11.5.2 Abbott Business Overview

11.5.3 Abbott Digital Companion Diagnostics Introduction

11.5.4 Abbott Revenue in Digital Companion Diagnostics Business (2018-2023)

11.5.5 Abbott Recent Development

11.6 ICON plc

11.6.1 ICON plc Company Detail

11.6.2 ICON plc Business Overview

11.6.3 ICON plc Digital Companion Diagnostics Introduction

11.6.4 ICON plc Revenue in Digital Companion Diagnostics Business (2018-2023)

11.6.5 ICON plc Recent Development

11.7 Illumina, Inc

11.7.1 Illumina, Inc Company Detail

11.7.2 Illumina, Inc Business Overview

11.7.3 Illumina, Inc Digital Companion Diagnostics Introduction

11.7.4 Illumina, Inc Revenue in Digital Companion Diagnostics Business (2018-2023)

11.7.5 Illumina, Inc Recent Development

11.8 Thermo Fisher

11.8.1 Thermo Fisher Company Detail

11.8.2 Thermo Fisher Business Overview

11.8.3 Thermo Fisher Digital Companion Diagnostics Introduction

11.8.4 Thermo Fisher Revenue in Digital Companion Diagnostics Business (2018-2023)

11.8.5 Thermo Fisher Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Digital Companion Diagnostics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Polymerase Chain Reaction (PCR)

    Table 3. Key Players of Immunohistochemistry (IHC)

    Table 4. Key Players of In Situ Hybridization (ISH)

    Table 5. Key Players of Next Generation Sequencing (NGS)

    Table 6. Global Digital Companion Diagnostics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Digital Companion Diagnostics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 8. Global Digital Companion Diagnostics Market Size by Region (2018-2023) & (US$ Million)

    Table 9. Global Digital Companion Diagnostics Market Share by Region (2018-2023)

    Table 10. Global Digital Companion Diagnostics Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 11. Global Digital Companion Diagnostics Market Share by Region (2024-2029)

    Table 12. Digital Companion Diagnostics Market Trends

    Table 13. Digital Companion Diagnostics Market Drivers

    Table 14. Digital Companion Diagnostics Market Challenges

    Table 15. Digital Companion Diagnostics Market Restraints

    Table 16. Global Digital Companion Diagnostics Revenue by Players (2018-2023) & (US$ Million)

    Table 17. Global Digital Companion Diagnostics Market Share by Players (2018-2023)

    Table 18. Global Top Digital Companion Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Digital Companion Diagnostics as of 2022)

    Table 19. Ranking of Global Top Digital Companion Diagnostics Companies by Revenue (US$ Million) in 2022

    Table 20. Global 5 Largest Players Market Share by Digital Companion Diagnostics Revenue (CR5 and HHI) & (2018-2023)

    Table 21. Key Players Headquarters and Area Served

    Table 22. Key Players Digital Companion Diagnostics Product Solution and Service

    Table 23. Date of Enter into Digital Companion Diagnostics Market

    Table 24. Mergers & Acquisitions, Expansion Plans

    Table 25. Global Digital Companion Diagnostics Market Size by Type (2018-2023) & (US$ Million)

    Table 26. Global Digital Companion Diagnostics Revenue Market Share by Type (2018-2023)

    Table 27. Global Digital Companion Diagnostics Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 28. Global Digital Companion Diagnostics Revenue Market Share by Type (2024-2029)

    Table 29. Global Digital Companion Diagnostics Market Size by Application (2018-2023) & (US$ Million)

    Table 30. Global Digital Companion Diagnostics Revenue Market Share by Application (2018-2023)

    Table 31. Global Digital Companion Diagnostics Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 32. Global Digital Companion Diagnostics Revenue Market Share by Application (2024-2029)

    Table 33. North America Digital Companion Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 34. North America Digital Companion Diagnostics Market Size by Country (2018-2023) & (US$ Million)

    Table 35. North America Digital Companion Diagnostics Market Size by Country (2024-2029) & (US$ Million)

    Table 36. Europe Digital Companion Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 37. Europe Digital Companion Diagnostics Market Size by Country (2018-2023) & (US$ Million)

    Table 38. Europe Digital Companion Diagnostics Market Size by Country (2024-2029) & (US$ Million)

    Table 39. Asia-Pacific Digital Companion Diagnostics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 40. Asia-Pacific Digital Companion Diagnostics Market Size by Region (2018-2023) & (US$ Million)

    Table 41. Asia-Pacific Digital Companion Diagnostics Market Size by Region (2024-2029) & (US$ Million)

    Table 42. Latin America Digital Companion Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 43. Latin America Digital Companion Diagnostics Market Size by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Digital Companion Diagnostics Market Size by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Digital Companion Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 46. Middle East & Africa Digital Companion Diagnostics Market Size by Country (2018-2023) & (US$ Million)

    Table 47. Middle East & Africa Digital Companion Diagnostics Market Size by Country (2024-2029) & (US$ Million)

    Table 48. Myriad Genetic Laboratories, Inc. Company Detail

    Table 49. Myriad Genetic Laboratories, Inc. Business Overview

    Table 50. Myriad Genetic Laboratories, Inc. Digital Companion Diagnostics Product

    Table 51. Myriad Genetic Laboratories, Inc. Revenue in Digital Companion Diagnostics Business (2018-2023) & (US$ Million)

    Table 52. Myriad Genetic Laboratories, Inc. Recent Development

    Table 53. Qiagen Manchester, Ltd. Company Detail

    Table 54. Qiagen Manchester, Ltd. Business Overview

    Table 55. Qiagen Manchester, Ltd. Digital Companion Diagnostics Product

    Table 56. Qiagen Manchester, Ltd. Revenue in Digital Companion Diagnostics Business (2018-2023) & (US$ Million)

    Table 57. Qiagen Manchester, Ltd. Recent Development

    Table 58. Roche Company Detail

    Table 59. Roche Business Overview

    Table 60. Roche Digital Companion Diagnostics Product

    Table 61. Roche Revenue in Digital Companion Diagnostics Business (2018-2023) & (US$ Million)

    Table 62. Roche Recent Development

    Table 63. Dako North America Company Detail

    Table 64. Dako North America Business Overview

    Table 65. Dako North America Digital Companion Diagnostics Product

    Table 66. Dako North America Revenue in Digital Companion Diagnostics Business (2018-2023) & (US$ Million)

    Table 67. Dako North America Recent Development

    Table 68. Abbott Company Detail

    Table 69. Abbott Business Overview

    Table 70. Abbott Digital Companion Diagnostics Product

    Table 71. Abbott Revenue in Digital Companion Diagnostics Business (2018-2023) & (US$ Million)

    Table 72. Abbott Recent Development

    Table 73. ICON plc Company Detail

    Table 74. ICON plc Business Overview

    Table 75. ICON plc Digital Companion Diagnostics Product

    Table 76. ICON plc Revenue in Digital Companion Diagnostics Business (2018-2023) & (US$ Million)

    Table 77. ICON plc Recent Development

    Table 78. Illumina, Inc Company Detail

    Table 79. Illumina, Inc Business Overview

    Table 80. Illumina, Inc Digital Companion Diagnostics Product

    Table 81. Illumina, Inc Revenue in Digital Companion Diagnostics Business (2018-2023) & (US$ Million)

    Table 82. Illumina, Inc Recent Development

    Table 83. Thermo Fisher Company Detail

    Table 84. Thermo Fisher Business Overview

    Table 85. Thermo Fisher Digital Companion Diagnostics Product

    Table 86. Thermo Fisher Revenue in Digital Companion Diagnostics Business (2018-2023) & (US$ Million)

    Table 87. Thermo Fisher Recent Development

    Table 88. Research Programs/Design for This Report

    Table 89. Key Data Information from Secondary Sources

    Table 90. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Digital Companion Diagnostics Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Digital Companion Diagnostics Market Share by Type: 2022 VS 2029

    Figure 3. Polymerase Chain Reaction (PCR) Features

    Figure 4. Immunohistochemistry (IHC) Features

    Figure 5. In Situ Hybridization (ISH) Features

    Figure 6. Next Generation Sequencing (NGS) Features

    Figure 7. Global Digital Companion Diagnostics Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 8. Global Digital Companion Diagnostics Market Share by Application: 2022 VS 2029

    Figure 9. Breast Cancer Case Studies

    Figure 10. Melanoma Case Studies

    Figure 11. Lung Cancer Case Studies

    Figure 12. Colorectal Cancer Case Studies

    Figure 13. Infectious Disease Case Studies

    Figure 14. Others Case Studies

    Figure 15. Digital Companion Diagnostics Report Years Considered

    Figure 16. Global Digital Companion Diagnostics Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 17. Global Digital Companion Diagnostics Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 18. Global Digital Companion Diagnostics Market Share by Region: 2022 VS 2029

    Figure 19. Global Digital Companion Diagnostics Market Share by Players in 2022

    Figure 20. Global Top Digital Companion Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Digital Companion Diagnostics as of 2022)

    Figure 21. The Top 10 and 5 Players Market Share by Digital Companion Diagnostics Revenue in 2022

    Figure 22. North America Digital Companion Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. North America Digital Companion Diagnostics Market Share by Country (2018-2029)

    Figure 24. United States Digital Companion Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. Canada Digital Companion Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. Europe Digital Companion Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. Europe Digital Companion Diagnostics Market Share by Country (2018-2029)

    Figure 28. Germany Digital Companion Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. France Digital Companion Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. U.K. Digital Companion Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Italy Digital Companion Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Russia Digital Companion Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Nordic Countries Digital Companion Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Asia-Pacific Digital Companion Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Asia-Pacific Digital Companion Diagnostics Market Share by Region (2018-2029)

    Figure 36. China Digital Companion Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Japan Digital Companion Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. South Korea Digital Companion Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Southeast Asia Digital Companion Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. India Digital Companion Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Australia Digital Companion Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Latin America Digital Companion Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Latin America Digital Companion Diagnostics Market Share by Country (2018-2029)

    Figure 44. Mexico Digital Companion Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Brazil Digital Companion Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Middle East & Africa Digital Companion Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Middle East & Africa Digital Companion Diagnostics Market Share by Country (2018-2029)

    Figure 48. Turkey Digital Companion Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 49. Saudi Arabia Digital Companion Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 50. Myriad Genetic Laboratories, Inc. Revenue Growth Rate in Digital Companion Diagnostics Business (2018-2023)

    Figure 51. Qiagen Manchester, Ltd. Revenue Growth Rate in Digital Companion Diagnostics Business (2018-2023)

    Figure 52. Roche Revenue Growth Rate in Digital Companion Diagnostics Business (2018-2023)

    Figure 53. Dako North America Revenue Growth Rate in Digital Companion Diagnostics Business (2018-2023)

    Figure 54. Abbott Revenue Growth Rate in Digital Companion Diagnostics Business (2018-2023)

    Figure 55. ICON plc Revenue Growth Rate in Digital Companion Diagnostics Business (2018-2023)

    Figure 56. Illumina, Inc Revenue Growth Rate in Digital Companion Diagnostics Business (2018-2023)

    Figure 57. Thermo Fisher Revenue Growth Rate in Digital Companion Diagnostics Business (2018-2023)

    Figure 58. Bottom-up and Top-down Approaches for This Report

    Figure 59. Data Triangulation

    Figure 60. Key Executives Interviewed